Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 2/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | CASP2 | P42575 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | F13A1 | P00488 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | CA6 | P23280 | 2/20 | 0.43 |
| ▸ | CA5A | P35218 | 2/20 | 0.43 |
| ▸ | THPO | P40225 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6890284 | 0.90 | GGT1 (0.55) | GGT1FOLH1NOD1GSR | |
| SCHEMBL146727 | 0.90 | GGT1 (0.55) | GGT1FOLH1NOD1GSR | |
| SCHEMBL6316197 | 0.89 | FOLH1 (0.54) | GGT1FOLH1CA2CA1NOD1 | |
| SCHEMBL6859366 | 0.89 | FOLH1 (0.54) | GGT1FOLH1CA2CA1NOD1 | |
| SCHEMBL12951159 | 0.86 | SIRT6 (0.46) | — | |
| SCHEMBL12085468 | 0.86 | SIRT6 (0.42) | CASP2CA12F13A1CA2CYP1A2 | |
| SCHEMBL19732599 | 0.85 | CA12 (0.43) | GGT1CASP2CA12F13A1CA2 | |
| SCHEMBL7076576 | 0.85 | FOLH1 (0.54) | GGT1FOLH1CA2PAOXCA1 | |
| SCHEMBL148480 | 0.85 | FOLH1 (0.54) | GGT1FOLH1CA2PAOXCA1 | |
| SCHEMBL12085570 | 0.84 | SIRT6 (0.48) | CASP2CA12F13A1CA2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3766981-A1 | CATIONIC POLOXAMERS AND THEIR USE IN TRANSDUCTION | OZ Biosciences (FR) | 2021-01-20 | — | — | EP | disclosed |
| US-10434186-B2 | Functionalized linear ligands and complexes thereof | LUMIPHORE, INC. (US) | 2019-10-08 | — | — | US | disclosed |
| US-20170360956-A1 | FUNCTIONALIZED LINEAR LIGANDS AND COMPLEXES THEREOF | LUMIPHORE, INC. | 2017-12-21 | — | — | US | disclosed |
| WO-2016106241-A1 | FUNCTIONALIZED LINEAR LIGANDS AND COMPLEXES THEREOF | LUMIPHORE, INC. (US) | 2016-06-30 | — | — | WO | disclosed |
| US-6107286-A | COMPLEXING WITH NUCLEIC ACIDS | RHONE-POULENC RORER S.A. (FR) | 2000-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360956-A1 | FUNCTIONALIZED LINEAR LIGANDS AND COMPLEXES THEREOF | CLTB, CLTA, EPCAM | GGT1 1670/4885FOLH1 196/4885CASP2 3804/4885 |
| US-10434186-B2 | Functionalized linear ligands and complexes thereof | CLTB, CLTA, EPCAM | GGT1 1670/4885FOLH1 196/4885CASP2 3804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.